Benserazide + Levodopa
Uses of Benserazide + Levodopa
This medication, classified as an anti-Parkinson's combination, is indicated for the treatment of Parkinson's disease to alleviate symptoms associated with the condition.
How Benserazide + Levodopa Works
Levodopa is converted into dopamine in the brain, compensating for the deficient levels in Parkinson's disease. Benserazide enhances the effectiveness of levodopa by preventing its conversion into dopamine outside the brain, ensuring a more significant amount reaches the central nervous system.
Side Effects of Benserazide + Levodopa
Nausea, dizziness, and headache. More severe side effects can include hallucinations, irregular heartbeat, and difficulty breathing.
Warnings
Kidney Limited Data
Limited data are available regarding the impact of this medication on kidney function. Consultation with a healthcare professional is recommended for individuals with kidney issues.
Alcohol Use With Care
Caution is advised when consuming alcohol while on this medication. Limited data are available, and it is recommended to consult with a healthcare professional regarding potential interactions.
Pregnancy Not Safe - High Risk
This medication is not considered safe during pregnancy due to high associated risks. Consultation with a healthcare provider is crucial to assess potential alternatives and risks.
Driving Use With Care
Caution is advised while driving or operating machinery, as this medication may cause dizziness or drowsiness. It is essential to assess individual response before engaging in activities that require alertness.
Liver Limited Data
Limited data are available on the effects of this medication on liver function. Caution is advised, and consultation with a healthcare professional is recommended, especially for individuals with liver conditions.
Lactation Limited Data
Limited data are available regarding the safety of this medication during lactation. Consultation with a healthcare professional is advised to determine potential risks and benefits.
Written by Dr Sri Viknarajan, MD (Universiti Hasanuddin, Indonesia)
Reviewed by Dr Nur Syuhada binti Zulkifli, MD, Universiti Kebangsaan Malaysia (UKM).
